GoldenGolden
Advanced Search
Girihlet

Girihlet

Girihlet provides an immune map database. Its platform aims to accelerate immune diseases discovery, monitoring and therapeutic approaches.

Girihlet’s T and B cell sequencing assays and immune map database allow predictions and measurements on a person’s health status and provide an un understanding of the immune system in order to treat cancer, allergies, infections and autoimmune disease.

Timeline

August 2018
Girihlet raises a $2,500,000 seed round from Digitalis Ventures and True Ventures.
September 2015
Girihlet raises a $250,000 seed round from IndieBio and SOSV.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.